TABLE 4.
Viability assay | IC50 [μg/ml (μM)] |
|||
---|---|---|---|---|
Subtype 7 isolates |
Subtype 4 isolates |
|||
B | E | WR-1 | S | |
Resazurin | 32.5 ± 3.4 (189.8) | NSa | 5.5 ± 2.89 (32.16) | 0.75 ± 0.04 (4.38) |
XTT | 29 ± 3.4 (169.36) | NS | 1.76 ± 0.39 (10.27) | 1.1 ± 0.08 (6.4) |
NS, not susceptible to drug concentrations of ≤100 μg/ml.